METHOD OF PREDICTING SPOT FORMATION ON THE SKIN WITH THE USE OF SPOT SITE-ACCELERATING GENES AS INDICATION AND METHOD OF SCREENING INHIBITOR FOR SPOT FORMATION ON THE SKIN
申请人:SHISEIDO COMPANY LIMITED
公开号:EP1691199A1
公开(公告)日:2006-08-16
The present invention provides a skin test method for predicting the formation of spots in the skin. This method judges skin to be susceptible to the formation of spots in the case expression in the epidermis of MCP-2 gene, a polynucleotide capable of hybridizing under highly stringent conditions to mouse AK012157 gene, human FLJ21763 gene or rat S74257 gene, or Mcp9, Mcp10, Isg15, Usp18, Oas12, Gbp2, Gtpi, Ifi47, Igtp, Tgtp, Sprr2A, Krt2-6b, Cdk5rap2, Mef2C, Gsta4, Osf2, Tnc, Igfbp6, Ppicap or Mm. 74656 gene, is increased as compared with normal expression in the epidermis.
本发明提供了一种预测皮肤斑点形成的皮肤测试方法。该方法判断皮肤在表皮中表达 MCP-2 基因的情况下容易形成斑点,MCP-2 基因是一种多核苷酸,能在高度严格的条件下与小鼠 AK012157 基因、人类 FLJ21763 基因或大鼠 S74257 基因、或 Mcp9、Mcp10、Isg15、Usp15 基因杂交、人 FLJ21763 基因或大鼠 S74257 基因,或 Mcp9、Mcp10、Isg15、Usp18、Oas12、Gbp2、Gtpi、Ifi47、Igtp、Tgtp、Sprr2A、Krt2-6b、Cdk5rap2、Mef2C、Gsta4、Osf2、Tnc、Igfbp6、Ppicap 或 Mm.与表皮中的正常表达量相比,74656 基因的表达量有所增加。